Transfer 60 CHF to the official BSNL bank account:
IBAN: CH50 0900 0000 8946 8243 2
PostFinance AG BERN
BSNL- BioScience Network Lausanne
P.a. EPFL AA DAF
Make sure to include the following line as the reason for payment: “Syngenta visit”
Send an email to firstname.lastname@example.org with the proof of payment.
Include “YourName Syngenta visit” in the subject line
The Faculty of Biology and Medicine of LAUSANNE
and the Faculty of Medicine of Geneva
are very pleased to present the 1stMedLem Meeting
that will held on Thursday, the 17th of November 2016
in Geneva-Centre Louis Jeantet.
The 2016 theme is
« INFLAMMATION in the era of BIG DATA ».
Invited Speakers :
- Prof. Francine Behar-Cohen (Hôpital opthtalmique Jules-Gonin)
- Dr. Lydie Lane (Swiss Institute of Bioinformatics)
- Dr. Luc Stoppini (Hepia//HES-SO and Swiss Centre for Applied Human Toxicology)
Deadline Abstract: 30.09.2016
(More info at www.unil.ch/medlem/)
The MedLem meeting will be a fantastic opportunity to discover the breadth of research around Lake Geneva
We encourage you to participate!
Scientific & organizing committee:
- Olivier Gaide (Department of Dermatology and Venereology, Lausanne University Hospital) contact
- Maxime Pellegrin (Division of Angiology, Lausanne University Hospital) contact
- Aurélien Thomas (Unit of Toxicology, CURML, Lausanne University Hospital, Geneva University Hospital) contact
- Natacha Turck (Department of Human Protein Sciences, University Medical Center-Geneva) contact
The ISCB regional student group for Computational Biology in Switzerland is very pleased to host the talk “Systems approaches to unravel molecular mechanisms of cancer ” by
María Rodríguez Martínez, Technical Leader of Systems Biology at IBM, Zurich Research Lab, on Wednesday the 7th of September 2016 at 18:00 at UZH, Irchel campus, Y03-G91.
Abstract: Despite their great promise, high-throughput technologies in cancer research have often failed to translate into major therapeutic advances in the clinic. One challenge lies in the difficulty of transforming next generation molecular data into mathematical disease models that can make actionable clinical statements. A second challenge arises from the high level of intra-tumor heterogeneity exhibited by most human cancers. To address these challenges new methodologies that can reconstruct the map of genomic alterations and understand its influence on phenotype need to be developed. In this talk I will give an overview of current projects at the Systems Biology group in IBM Research, Zurich, that illustrate systems medicine approaches to understand cancer complexity and that can bridge the chasm between basic research and clinical applications.
The talk will be followed by an apéro, during which participants will have the opportunity to continue discussions with María Rodríguez Martínez.
We are looking forward to seeing you at the event!
The RSG Switzerland Team